NICE has published a draft of the revised clinical guideline Management of multiple sclerosis in primary and secondary care and has invited comments from registered stakeholders.
A letter to The Telegraph today suggests that more than half of people with MS in the UK may not be getting access to treatments they need.
A free app (SymTrac) that enables people to track their MS over time was launched yesterday.
The Scottish Medicines Consortium (SMC) has approved dimethyl fumarate (BG-12, Tecfidera) as a treatment for relapsing remitting multiple sclerosis on the NHS in Scotland.
The MS Trust welcomes the decision by SMC.